A live cell PRMT5 NanoBRETT target engagement assay querying competitive and uncompetitive modes of inhibition

被引：0
|
作者：
Teske, Kelly A.
Michaud, Ani
Rothweiler, Elisabeth
Corona, Cesear
Hoffman, Kaitlin Dunn
Wilkinson, Jennifer
Beck, Michael
Vasta, James
Huber, Kilian
Robers, Matthew
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2024年 / 23卷 / 06期
关键词：
D O I：
10.1158/1538-8514.SYNTHLETH24-A005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A005
引用
收藏
页数：2
相关论文
共 33 条
  • [21] PRMT5 Inhibition Alters Mitochondrial Dynamics in Mantle Cell Lymphoma Creating Vulnerability to BH3 Mimetic Compounds
    Hinterschied, Claire
    Brown, Fiona
    Ravikrishnan, Janani
    Helmig-Mason, Jobeth
    Harrison, Kaylee R.
    Yasin, Aneeq
    Sloan, Shelby
    Long, Mackenzie
    Bhagwat, Neha
    Vaddi, Kris
    Scherle, Peggy
    Woyach, Jennifer A.
    Chen-Kiang, Selina
    Elemento, Olivier
    Paik, Jihye
    Baiocchi, Robert A.
    BLOOD, 2022, 140 : 3118 - 3119
  • [22] PRMT5 Inhibition Potentiates Anti-Tumor Immune Targeting of EBV-Driven B Cell Lymphoproliferative Disease
    Ahmed, Elshafa Hassan
    Weigel, Christoph
    Saadey, Rachel
    Brooks, Eric
    Cash, Taylor
    Mao, Charlene
    Yasin, Aneeq
    Wandke, Alexa
    Baiocchi, Ethan
    Mozhenkova, Anna
    Brown, Fiona
    Sloan, Shelby
    Helmig-Mason, JoBeth
    Harrison, Kaylee
    Vaddi, Kris
    Scherle, Peggy
    Bhagwat, Neha
    Chan, Wing Keung
    Elemento, Olivier
    Mason, Christopher E.
    Oakes, Christopher C.
    Baiocchi, Robert A.
    Shindiapina, Polina
    BLOOD, 2022, 140 : 3116 - 3117
  • [23] Loss of METTL3 attenuates blastic plasmacytoid dendritic cell neoplasm response to PRMT5 inhibition via IFN signaling
    Rethnam, Malini
    Tan, Darren Qiancheng
    Tan, Shi Hao
    Li, Jia
    Yokomori, Rui
    Li, Ying
    Yang, Henry
    Sanda, Takaomi
    Suda, Toshio
    BLOOD ADVANCES, 2022, 6 (18) : 5330 - 5344
  • [24] Inhibition of PRMT5 Disrupts Cell Cycle Progression and DNA Damage Signaling, Revealing a Potential Novel Combination Therapy for Pancreatic Cancer
    Hc, Lishu
    Urrutia, Guillermo
    Lomberk, Gwen
    FASEB JOURNAL, 2022, 36
  • [25] Screening non-small cell lung cancer patient-derived organoids with epigenetic probes reveals PRMT5 as an oncogenic target
    Jafarova, Khadija
    Li, Quan
    Radulovich, Nikolina
    Liu, Geoffrey
    Tsao, Ming S.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
  • [26] PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival
    Panfil, Amanda R.
    Al-Saleem, Jacob
    Howard, Cory M.
    Mates, Jessica M.
    Kwiek, Jesse J.
    Baiocchi, Robert A.
    Green, Patrick L.
    VIRUSES-BASEL, 2016, 8 (01):
  • [27] PRMT5 promotes STAT-1 mediated T cell inflammatory response and is a therapeutic target for acute graft-versus-host disease
    Snyder, Katiri Jenna
    Zitzer, Nina C.
    Gao, Yandi
    Choe, Hannah K.
    Sell, Natalie E.
    Neidemire-Colley, Lotus
    Devine, Raymond
    Behbehani, Gregory
    Pietrzak, Maciej
    Vaddi, Kris
    Baiocchi, Robert
    Ranganathan, Parvathi
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [28] MTA-cooperative PRMT5 inhibition (BMS-986504) induces MTAP del tumor cell-intrinsic immune evasion and regulation
    Hai, Josephine
    Xavier, Stephanie
    George, Sangeeth
    Engstrom, Lars
    Olson, Pete
    Simpson, Tyler
    Lei, Ming
    Chen, Benjamin
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [29] Synthetic lethality of PRMT5 inhibition in NDRG2-deficient adult T-cell leukemia through HSP90A dysfunction
    Ichikawa, Tomonaga
    Shanab, Obeid
    Nakahata, Shingo
    Shimosaki, Shunsuke
    Manachai, Nawin
    Ono, Masaya
    Iha, Hidekatsu
    Shimoda, Kazuya
    Ismail, Mohammed
    Nassar, Ahmed
    Morishita, Kazuhiro
    CANCER SCIENCE, 2018, 109 : 40 - 40
  • [30] Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2low Adult T-Cell Leukemia/Lymphoma
    Ichikawa, Tomonaga
    Suekane, Akira
    Nakahata, Shingo
    Iha, Hidekatsu
    Shimoda, Kazuya
    Murakami, Takashi
    Morishita, Kazuhiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (05)
1234